EMS-CHEMIE

Ems Chemie shares rose 1.8% to CHF 782.5, extending the recovery trend since the publication of the half-year results. In the first half-year the company reported net sales of CHF 1,012m and an operating result of CHF 310m; the EBIT margin rose to 30.6% and the EBITDA margin to 33.2%, and net profit increased by 2.5%. The results were achieved despite headwinds from a stronger Swiss franc and demonstrate robust demand in high-performance polymers and specialty chemicals. The share price recovered from a 52-week low of CHF 530 to a high of CHF 839.5; current market conditions provided no new company-specific catalysts. » More on de.investing.com

Ems Chemie beat expectations for the first half of 2026: EBIT rose 4.7% to CHF 310 million with an EBIT margin of 30.6%, and EBITDA climbed to CHF 336 million (EBITDA margin 33.2%). Management raised its net sales guidance despite a headwind from a markedly stronger Swiss franc. As an incentive for shareholders, the board proposes a total dividend of CHF 18.40 per share, higher than last year. According to the company, growth is being driven mainly by metal substitution, energy savings, and demand from electric vehicles, robotics and data centers. » More on de.investing.com

EMS recorded a revenue decline of 0.8% to CHF 1.01 billion in the first half of 2026 (currency effects -5.2%), but sold more by volume and increased EBIT by 4.7% to CHF 310 million. The EBIT margin rose by 1.5 percentage points to 30.6%; rising raw material costs were offset by higher selling prices. EMS beat analyst expectations and slightly raised its forecast for net sales; EBIT is still expected to be slightly above last year. » More on finanzen.net